India’s Divi’s Labs misses profit estimates on higher expenses
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
India’s Divi’s Laboratories reported a bigger-than-expected fall in quarterly profit on Monday, dragged down by higher expenses at a time when generic drug makers have flagged easing price pressures in key markets such as the United States.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1358880761-82e600bfa20f4c2a8c48dc39cebeb0b0.jpg "<div>Accountant vs. Controller: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/Primary-Image-td-bank-cd-rates-march-2023-7482856-1d7d5a82f0ca496b9b1d63739cd7f567.jpg "TD Bank CD Rates: November 2024")
:max_bytes(150000):strip_icc():format(jpeg)/Primary-Image-fidelity-cd-rates-may-2023-7496602-4e8485ac0a5349a5bb10885241012896.jpg "Fidelity CD Rates: November 2024")